Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |
| Motus GI Holdings Inc. | 2 | 0 | 0 | 0 | €0.43 | €2.33 | 443.991% |
| X4 Pharmaceuticals, Inc. | 6 | 0 | 3 | 0 | €1.01 | €2.78 | 175.114% |
| Lightpath Techs A | 3 | 0 | 0 | 0 | €1.32 | €2.78 | 110.879% |
| ProQR Therapeutics N.V. | 6 | 0 | 1 | 0 | €1.84 | €2.81 | 52.814% |
| Precision BioSciences Inc | 7 | 0 | 1 | 0 | €0.35 | €2.90 | 734.167% |
| Aclaris Therapeutics Inc | 1 | 0 | 1 | 0 | €1.26 | €3.00 | 138.095% |
| SCYNEXIS Inc. | 5 | 0 | 0 | 0 | €1.66 | €3.00 | 80.723% |
| Personalis Inc | 6 | 0 | 2 | 0 | €1.50 | €3.24 | 116.640% |
| Cerus Corp. | 4 | 0 | 2 | 0 | €1.72 | €3.26 | 89.872% |
| Akebia Therapeutics Inc. | 8 | 3 | 1 | 0 | €1.30 | €3.60 | 177.494% |
| Compugen Ltd. | 3 | 2 | 1 | 0 | €2.01 | €3.67 | 82.813% |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.40 | €3.70 | 164.475% |
| Atossa Genetics Inc | 5 | 1 | 1 | 0 | €1.60 | €3.72 | 132.110% |
| Cutera Inc. | 2 | 0 | 1 | 0 | €2.55 | €3.75 | 46.944% |
| Immutep LTD ADR | 1 | 0 | 0 | 0 | €2.70 | €4.00 | 48.148% |
| Lisata Therapeutics Inc. | 1 | 0 | 0 | 0 | €2.50 | €4.00 | 60.000% |
| Xeris Biopharma Holdings Inc. | 4 | 0 | 0 | 0 | €1.76 | €4.39 | 149.506% |
| Heron Therapeutics Inc. | 9 | 1 | 4 | 0 | €2.66 | €4.57 | 71.689% |
| Emergent Biosolutions Inc. | 2 | 3 | 1 | 0 | €4.11 | €4.62 | 12.473% |
| Geron Corp. | 12 | 0 | 4 | 0 | €3.59 | €4.63 | 28.709% |
| Cara Therapeutics Inc. | 8 | 1 | 1 | 0 | €0.74 | €4.63 | 523.055% |
| Adverum Biotechnologies Inc. | 6 | 1 | 2 | 0 | €1.38 | €4.66 | 237.768% |
| Vanda Pharmaceuticals | 4 | 0 | 1 | 0 | €5.10 | €5.00 | -1.961% |
| Lexicon Pharmaceuticals Inc. | 2 | 0 | 1 | 0 | €1.65 | €5.34 | 223.394% |